Merck has struck a deal worth up to $1.3 billion to buy an investigational drug targeting B-cell associated diseases.
Related Posts
Honeywell Strikes $1.8 Billion Deal for Liquefied Natural Gas Business
Honeywell will buy the Air Products unit in its fourth acquisition in recent months as natural-gas demand grows.
This Chinese Miner Dominates Global Cobalt Supply. The U.S. Is Crying Foul.
With its rapid expansion in Africa, CMOC has seized the lead position in the metal used in EV batteries and weapons.
How Elon Musk Went Red Against California Blue
As he embraced the Republican Party this week, the billionaire rejected the birthplace of Tesla and SpaceX.